Zhang Y, Gauthier SA, Gupta A, Comunale J, Chiang GChia-Yi, Zhou D, Chen W, Giambrone AE, Zhu W, Wang Y.  2016.  Longitudinal change in magnetic susceptibility of new enhanced multiple sclerosis (MS) lesions measured on serial quantitative susceptibility mapping (QSM).. J Magn Reson Imaging. 44(2):426-32.

Osorio RS, Ducca EL, Wohlleber ME, Tanzi EB, Gumb T, Twumasi A, Tweardy S, Lewis C, Fischer E, Koushyk V et al..  2016.  Orexin-A is Associated with Increases in Cerebrospinal Fluid Phosphorylated-Tau in Cognitively Normal Elderly Subjects.. Sleep. 39(6):1253-60.

Dayan M, Monohan E, Pandya S, Kuceyeski A, Nguyen TD, Raj A, Gauthier SA.  2016.  Profilometry: A new statistical framework for the characterization of white matter pathways, with application to multiple sclerosis.. Hum Brain Mapp. 37(3):989-1004.

Habeck C, Gazes Y, Razlighi Q, Steffener J, Brickman A, Barulli D, Salthouse T, Stern Y.  2016.  The Reference Ability Neural Network Study: Life-time stability of reference-ability neural networks derived from task maps of young adults.. Neuroimage. 125:693-704.

Lee S, Habeck C, Razlighi Q, Salthouse T, Stern Y.  2016.  Selective association between cortical thickness and reference abilities in normal aging.. Neuroimage. 142:293-300.

Gazes Y, F Bowman DB, Razlighi QR, O'Shea D, Stern Y, Habeck C.  2016.  White matter tract covariance patterns predict age-declining cognitive abilities.. Neuroimage. 125:53-60.

Oh H, Steffener J, Razlighi QR, Habeck C, Stern Y.  2016.  β-Amyloid Deposition Is Associated with Decreased Right Prefrontal Activation during Task Switching among Cognitively Normal Elderly.. J Neurosci. 36(6):1962-70.

Sampedro F, Vilaplana E, de Leon MJ, Alcolea D, Pegueroles J, Montal V, Carmona-Iragui M, Sala I, Sánchez-Saudinos M-B, Antón-Aguirre S et al..  2015.  APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls.. Oncotarget. 6(29):26663-74.

Oh H, Steffener J, Razlighi QR, Habeck C, Liu D, Gazes Y, Janicki S, Stern Y.  2015.  Aβ-related hyperactivation in frontoparietal control regions in cognitively normal elderly.. Neurobiol Aging. 36(12):3247-3254.

Salthouse TA, Habeck C, Razlighi Q, Barulli D, Gazes Y, Stern Y.  2015.  Breadth and age-dependency of relations between cortical thickness and cognition.. Neurobiol Aging. 36(11):3020-3028.

Gazes Y, Habeck C, O'Shea D, Razlighi QR, Steffener J, Stern Y.  2015.  Functional network mediates age-related differences in reaction time: a replication and extension study.. Brain Behav. 5(5):e00324.

Habeck C, Steffener J, Barulli D, Gazes Y, Razlighi Q, Shaked D, Salthouse T, Stern Y.  2015.  Making cognitive latent variables manifest: distinct neural networks for fluid reasoning and processing speed.. J Cogn Neurosci. 27(6):1249-58.

Blum S, Habeck C, Steffener J, Razlighi Q, Stern Y.  2014.  Functional connectivity of the posterior hippocampus is more dominant as we age.. Cogn Neurosci. 5(3-4):150-9.

Stern Y, Habeck C, Steffener J, Barulli D, Gazes Y, Razlighi Q, Shaked D, Salthouse T.  2014.  The Reference Ability Neural Network Study: motivation, design, and initial feasibility analyses.. Neuroimage. 103:139-151.

Steffener J, Barulli D, Habeck C, O'Shea D, Razlighi Q, Stern Y.  2014.  The role of education and verbal abilities in altering the effect of age-related gray matter differences on cognition.. PLoS One. 9(3):e91196.

Razlighi QR, Habeck C, Steffener J, Gazes Y, Zahodne LB, Mackay-Brandt A, Stern Y.  2014.  Unilateral disruptions in the default network with aging in native space.. Brain Behav. 4(2):143-57.

Mattsson N, Rosén E, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka S-K, van der Flier WM, Blankenstein MA, Ewers M et al..  2012.  Age and diagnostic performance of Alzheimer disease CSF biomarkers.. Neurology. 78(7):468-76.

Glodzik L, Mosconi L, Tsui W, de Santi S, Zinkowski R, Pirraglia E, Rich KE, McHugh P, Li Y, Williams S et al..  2012.  Alzheimer's disease markers, hypertension, and gray matter damage in normal elderly.. Neurobiol Aging. 33(7):1215-27.

Kosenko EA, Aliev G, Tikhonova LA, Li Y, Poghosyan AC, Kaminsky YG.  2012.  Antioxidant status and energy state of erythrocytes in Alzheimer dementia: probing for markers.. CNS Neurol Disord Drug Targets. 11(7):926-32.

Wu WE, Gass A, Glodzik L, Babb JS, Hirsch J, Sollberger M, Achtnichts L, Amann M, Monsch AU, Gonen O.  2012.  Whole brain N-acetylaspartate concentration is conserved throughout normal aging.. Neurobiol Aging. 33(10):2440-7.

Rusinek H, Brys M, Glodzik L, Switalski R, Tsui W-H, Haas F, McGorty K, Chen Q, de Leon MJ.  2011.  Hippocampal blood flow in normal aging measured with arterial spin labeling at 3T.. Magn Reson Med. 65(1):128-37.

Mosconi L, Mistur R, Switalski R, Brys M, Glodzik L, Rich K, Pirraglia E, Tsui W, De Santi S, de Leon MJ.  2009.  Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease.. Neurology. 72(6):513-20.

Glodzik-Sobanska L, Pirraglia E, Brys M, de Santi S, Mosconi L, Rich KE, Switalski R, Louis LSaint, Sadowski MJ, Martiniuk F et al..  2009.  The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease.. Neurobiol Aging. 30(5):672-81.

Mosconi L, de Santi S, Li J, Tsui WHon, Li Y, Boppana M, Laska E, Rusinek H, de Leon MJ.  2008.  Hippocampal hypometabolism predicts cognitive decline from normal aging.. Neurobiol Aging. 29(5):676-92.

Glodzik L, King KG, Gonen O, Liu S, de Santi S, de Leon MJ.  2008.  Memantine decreases hippocampal glutamate levels: a magnetic resonance spectroscopy study.. Prog Neuropsychopharmacol Biol Psychiatry. 32(4):1005-12.